share_log

康方生物-B:與正大天晴進行有關派安普利(PD-1單抗(AK105))治療肝細胞癌的III期註冊試驗的持續關連交易物料及服務總採購協議

AKESO, INC. - B: CONTINUING CONNECTED TRANSACTIONS WITH CHIA TAI TIANQING IN RELATION TO PHASE III REGISTRATION TRIAL OF PENPULIMAB (PD-1 MONOCLONAL ANTIBODY, AK105) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA MASTER MATERIALS AND SERVICES PROCUREMENT AG

Sep 20, 2022 10:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more